Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfacetamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.89 |
| ▸ | DHFR | P00374 | 1/20 | 0.89 |
| ▸ | TSHR | P16473 | 1/20 | 0.89 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.89 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | MMP1 | P03956 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
| ▸ | MMP9 | P14780 | 1/20 | 0.53 |
| ▸ | MMP8 | P22894 | 1/20 | 0.53 |
| ▸ | MMP13 | P45452 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfacetamide SCHEMBL15869608 | 0.98 | SMN1; SMN2 (0.93) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL28182511 | 0.96 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL2503539 | 0.96 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL23317 | 0.96 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL40863 | 0.94 | SMN1; SMN2 (1.00) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL28122264 | 0.94 | SMN1; SMN2 (1.00) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL16097762 | 0.93 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL29207414 | 0.93 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL3912378 | 0.93 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL28308067 | 0.93 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014027006-A1 | BIOADHESIVE FORMULATIONS FOR USE IN DRUG DELIVERY | EDKO PAZARLAMA TANITIM TICARET LIMITED SIRKETI (TR) | 2014-02-20 | — | — | WO | disclosed |